UFP Technologies

UFP Technologies, Inc. engages in designing and custom manufacturing of components, subassemblies, products and packaging utilizing specialized foams, films, and plastics primarily for the medical market. The firm manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It’s single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The firm also providing highly engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets. Its products include military uniform and gear components, automotive interior trim, athletic padding, environmentally friendly protective packaging, air filtration, abrasive nail files, and protective cases and inserts. The company was founded by Richard L. Bailly, Robert W. Drew, Sr. and William H. Shaw in 1963 and is headquartered in Newburyport, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEWBURYPORT, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $9.7 million or $1.27 per diluted common share outstanding for its first quarter ended March 31, 2023, compared to net income of $4.9 million or $0.64 per diluted common share outstanding for the first quarter of 2022. Net Sales for the first quarter were $97.8 million compared to 2022 first quarter sales of $71.2 million.

UFP Technologies Announces Record Q1 2023 Results

NEWBURYPORT, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced that Chairman & Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will present and host one-on-one meetings with investors at the Sidoti Virtual Investor Conference taking place on March 22-23, 2023.

UFP TECHNOLOGIES, INC. to Present Virtually and Host 1X1 Investor Meetings at Sidoti Virtual Investor Conference on March 22, 2023

NEWBURYPORT, Mass., March 07, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported net income of $41.8 million or $5.45 per diluted common share outstanding for its year ended December 31, 2022, compared to net income of $15.9 million or $2.09 per diluted common share outstanding for 2021. Net Sales for 2022 were $353.8 million compared to 2021 sales of $206.3 million.

UFP Technologies Announces Record 2022 Results

Advanced Micro Devices

Chipotle

New York Times

Old Dominion Freight Line

Polaris

Ferrari

While volatility persists, markets have managed to get off to a strong start in 2023. All three of the major U.S. stock indices are positive on the year, with the technology-laden Nasdaq leading the pack with a 14% year-to-date gain.

7 Stocks to Watch if You're Looking for the Next High Flyer

UFP Technologies continues its upward trajectory along the equity curve. Valuations still make sense on closer inspection, and investors are looking at a fair P/E of ~24.25x by estimation.

UFP Technologies: Further Re-Rating In FY 2023 More Than Possible

NEWBURYPORT, Mass., Nov. 15, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman & CEO R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate at the Southwest IDEAS Investor Conference on November 16, 2022. UFP Technologies' presentation is scheduled to begin at 3:00 pm CT on November 16. The presentation will be webcast and can be accessed through the conference site, www.IDEASconferences.com, and in the investor relations section of the company's website: www.UFPT.com/Investors.

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Southwest IDEAS Investor Conference November 16

NEWBURYPORT, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $19.5 million or $2.56 per diluted common share outstanding for its third quarter ended September 30, 2022, compared to net income of $3.8 million or $0.50 per diluted common share outstanding for the same quarter in 2021. Sales for the third quarter were $97.0 million compared to 2021 third quarter sales of $50.7 million. Net income for the nine-month period ended September 30, 2022 was $33.3 million or $4.37 per diluted common share outstanding compared to $12.7 million or $1.67 per diluted common share outstanding for the same period in 2021. Sales for the nine-month period ended September 30, 2022 were $262.6 million compared to sales of $150.0 million for the same period in 2021.

UFP Technologies Announces Record Q3 2022 Results

NEWBURYPORT, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- UFP Technologies (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products and packaging primarily for the medical market, today announced that R. Jeffrey Bailly, Chairman and CEO and Ronald J. Lataille, Sr. Vice President, Treasurer and Chief Financial Officer, will participate in the Sidoti September Small-Cap Virtual Conference on September 21, 2022. UFP Technologies' presentation will begin at 10:00 am ET on September 21, 2022 and can be accessed live at https://sidoti.zoom.us/webinar/register/WN_ysoqK5utQO6L9oId0mVIOA. It is also accessible in the investor relations section of the Company's website: www.ufpt.com. UFP Technologies will also host virtual one-on-ones with investors on Wednesday, September 21, 2022. To register for the presentation or one-on-ones, visit www.sidoti.com/events. Registration is free and you don't need to be a Sidoti client.

UFP Technologies to Present and Host 1X1 Investor Meetings at the Sidoti September Small-Cap Virtual Conference

UFP Technologies exhibits the kind of equity premia we are seeking exposure to in FY22. A 5-year normalized ROIC of 9.2% coupled with a pivot into medtech look to have positioned the company well looking ahead.

UFP Technologies: Molded Fiber Sale Adds ~$1.60/Share To Bottom-Line

NEWBURYPORT, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (“UFP”) (Nasdaq: UFPT) today announced the sale of its molded fiber business and related real estate in Iowa to CKF, Inc. for approximately $32 million.

UFP Technologies Sells Molded Fiber Business to CKF, Inc.

NEWBURYPORT, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) today announced the opening of a new medical manufacturing operation in Tijuana, Mexico. The 84,000-square-foot, FDA-registered facility will feature clean room and clean space medical device manufacturing and assembly.

UFP Technologies Expands to Mexico

NEWBURYPORT, Mass., June 21, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (“UFPT”), today announced R. Jeffrey Bailly, Chairman and Chief Executive Officer and Ron Lataille, Chief Financial Officer will participate in the virtual East Coast IDEAS Investor Conference on June 22 and 23, 2022. UFP Technologies, Inc.'s presentation is scheduled to be available at 6:00 am ET on June 22 and will be accessible through the conference site. The presentation will also be webcast and can be accessed through the conference website, the host's main website: www.IDEASconferences.com, and in the investor relations section of the company's website: www.UFPT.com.

UFP Technologies, Inc. to Present Virtually and Host 1x1 Investor Meetings at the 12th Annual East Coast IDEAS Investor Conference on June 22 and 23, 2022

NEWBURYPORT, Mass., June 14, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom converter of foams, plastics, and natural fiber materials primarily for the medical market, today announced that R. Jeffrey Bailly, Chairman and Chief Executive Officer, and Ron Lataille, Chief Financial Officer, will present and host one-on-one meetings with investors at the Sidoti Fall Virtual Investor Conference taking place on June 15-16, 2022.

UFP Technologies, Inc. to Present Virtually and Host 1X1 Investor Meetings at Sidoti Virtual Investor Conference on June 16, 2022

On Friday, UFP Technologies got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96. The post UFP Technologies Sees Its Composite Rating Rise To 96 appeared first on Investor's Business Daily.

UFP Technologies Sees Its Composite Rating Rise To 96

NEWBURYPORT, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $4.9 million or $0.64 per diluted common share outstanding for its first quarter ended March 31, 2022, compared to net income of $4.2 million or $0.55 per diluted common share outstanding for the same quarter in 2021. Sales for the first quarter were $71.2 million compared to 2021 first quarter sales of $48.6 million.

UFP Technologies Announces Strong Q1 2022 Results

Greif

GEF vs. UFPT: Which Stock Is the Better Value Option?

GEF or UFPT: Which Is the Better Value Stock Right Now?

NEWBURYPORT, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Advant Medical Ltd. Founded in 1993 and headquartered in Galway, Ireland, with operations in Costa Rica and partner manufacturing in Mexico, Advant Medical is a developer and manufacturer of Class I, II, and III medical devices and packaging.

UFP Technologies, Inc. Acquires Advant Medical Ltd.

NEWBURYPORT, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $15.9 million or $2.09 per diluted common share outstanding for its year ended December 31, 2021, compared to net income of $13.4 million or $1.77 per diluted common share outstanding for 2020. Sales for 2021 were $206.3 million compared to 2020 sales of $179.4 million.

UFP Technologies Announces 2021 Results

NEWBURYPORT, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of DAS Medical, Inc. Founded in 2010 and headquartered in Atlanta, Georgia, with manufacturing in the Dominican Republic, DAS is a medical device contract manufacturer specializing in the design, development and production of single-use surgical equipment covers, robotic draping systems and fluid control pouches.

UFP Technologies Acquires DAS Medical

UFP (UFPT) delivered earnings and revenue surprises of -12.28% and 4.58%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

UFP Technologies (UFPT) Lags Q3 Earnings Estimates

NEWBURYPORT, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $3.8 million or $0.50 per diluted common share outstanding for its third quarter ended September 30, 2021, compared to net income of $3.0 million or $0.40 per diluted common share outstanding for the same quarter in 2020. Sales for the third quarter were $50.7 million compared to 2020 third quarter sales of $43.3 million. Net income for the nine-month period ended September 30, 2021 was $12.7 million or $1.67 per diluted common share outstanding compared to $9.2 million or $1.22 per diluted common share outstanding for the same period in 2020. Sales for the nine-month period ended September 30, 2021 were $150.0 million compared to sales of $134.2 million for the same period in 2020.

UFP Technologies Announces Q3 2021 Results

UFP (UFPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

UFP Technologies (UFPT) Earnings Expected to Grow: Should You Buy?

DEDHAM, Mass.--(BUSINESS WIRE)--Healthcare product manufacturer and distributor, AliMed, Inc. (www.alimed.com) announced the promotion of Adam S. Epstein to Chief Executive Officer.

Healthcare Supplier and Manufacturer AliMed, Inc. Names Adam S. Epstein as Chief Executive Officer

NEWBURYPORT, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Contech Medical, Inc. Founded in 1987 and headquartered in Providence, Rhode Island, with partner manufacturing in Costa Rica, Contech Medical is a global leader in the design, development, and manufacture of class III medical device packaging primarily for catheters and guidewires. Annual sales are approximately $18 million.

UFP Technologies, Inc. Acquires Contech Medical, Inc.

NEWBURYPORT, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom converter of foams, plastics, and natural fiber materials primarily for the medical market, today announced that R. Jeffrey Bailly, Chairman and Chief Executive Officer, and Ron Lataille, Chief Financial Officer, will present and host one-on-one meetings with investors at the Sidoti Fall Virtual Investor Conference, taking place on September 22-23, 2021.

News for UFP Technologies Stock (UFPT)